SPRB (Spruce Biosciences) Purchase Of Property, Plant, Equipment: $-0.01 Mil (TTM As of Mar. 2026)


SPRB Spruce Biosciences Inc SPRB
35 GF Score
Price $51.31
GF Value $4.08
Valuation Significantly Overvalued
! 1 Warning Sign
View Full Analysis

What is Spruce Biosciences Purchase Of Property, Plant, Equipment?

Spruce Biosciences SPRB -2.20% 35 Purchase Of Property, Plant, Equipment is $-0.01 Mil as of Mar. 2026. GuruFocus rates SPRB with a GF Score™ of 35/100 and a GF Value™ of $4.08 (Significantly Overvalued). The stock has 1 warning sign investors should review.

Spruce Biosciences's purchase of property, plant, equipment for the three months ended in Mar. 2026 was $-0.01 Mil. It means Spruce Biosciences spent $0.01 Mil on purchasing property, plant, equipment. Spruce Biosciences's purchase of property, plant, equipment for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.01Mil.

Compared with last quarter ($0.00 Mil in Dec. 2025 ), Spruce Biosciences spent more money on purchasing property, plant, equipment in Mar. 2026 ($-0.01 Mil).


Spruce Biosciences Purchase Of Property, Plant, Equipment Related Terms


Spruce Biosciences Purchase Of Property, Plant, Equipment Historical Data

* Premium members only.

The historical data trend for Spruce Biosciences's Purchase Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Spruce Biosciences Purchase Of Property, Plant, Equipment Chart

Spruce Biosciences Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Purchase Of Property, Plant, Equipment
Get a 7-Day Free Trial -0.09 -0.01 -0.01 0.00 0.00

Spruce Biosciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Purchase Of Property, Plant, Equipment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -0.01
SPRB
35GF Score
Spruce Biosciences Inc SPRB
Purchase Of Property, Plant, Equipment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Spruce Biosciences Purchase Of Property, Plant, Equipment Calculation

The amount used to purchase PPE.

Purchase Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Purchase Of Property, Plant, Equipment of $-0.01 Mil mean?
Spruce Biosciences (SPRB) has a Purchase Of Property, Plant, Equipment of $-0.01 Mil as of Mar. 2026. Purchase of PP&E is the total purchase of property, plant and equipment. View historical data for Spruce Biosciences and its competitors.
Is Spruce Biosciences' Purchase Of Property, Plant, Equipment too high?
Spruce Biosciences' current Purchase Of Property, Plant, Equipment is $-0.01 Mil. Overall, Spruce Biosciences has a GF Score™ of 35/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Spruce Biosciences' Purchase Of Property, Plant, Equipment compare to HURA and AGEN?
Spruce Biosciences' Purchase Of Property, Plant, Equipment of $-0.01 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Purchase Of Property, Plant, Equipment for a Biotechnology company?
A good Purchase Of Property, Plant, Equipment depends on the Biotechnology industry context. However, Purchase Of Property, Plant, Equipment should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Purchase Of Property, Plant, Equipment mean?
A high Purchase Of Property, Plant, Equipment can signal that a stock is expensive relative to its fundamentals. Purchase of PP&E is the total purchase of property, plant and equipment. View historical data for Spruce Biosciences and its competitors. Spruce Biosciences's current Purchase Of Property, Plant, Equipment is $-0.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spruce Biosciences stock overvalued right now?
Based on GuruFocus' analysis, Spruce Biosciences (SPRB) is currently considered Significantly Overvalued. The stock's GF Value™ is $4.08, compared to a current price of $51.31 — trading 1157.5% above its estimated fair value. The current Purchase Of Property, Plant, Equipment is $-0.01 Mil. Spruce Biosciences' overall GF Score™ is 35/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Purchase Of Property, Plant, Equipment calculated?
Purchase Of Property, Plant, Equipment is calculated from a company's financial statements. For Spruce Biosciences (SPRB), the current Purchase Of Property, Plant, Equipment is $-0.01 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Spruce Biosciences (SPRB) Overvalued in 2026?

Based on GuruFocus' analysis, Spruce Biosciences stock appears to be overvalued. The current stock price of $51.31 is trading 1157.5% above its estimated GF Value™ of $4.08. GuruFocus considers Spruce Biosciences to be Significantly Overvalued.

Key valuation signals for SPRB:

  • Purchase Of Property, Plant, Equipment: $-0.01 Mil
  • GF Value™: $4.08 vs. price of $51.31 (1157.5% above fair value)
  • GF Score™: 35/100 with 1 warning sign

No single metric tells the full story. See the SPRB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Spruce Biosciences Business Description

Address 611 Gateway Boulevard, Suite 740, South San Francisco, CA, USA, 94080
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The company develops biologics and small-molecule product candidates aimed at addressing diseases with unmet medical needs and limited or no approved therapies. Its product candidate, TA-ERT for the treatment of Mucopolysaccharidosis Type IIIB (MPS IIIB), is a fusion protein comprised of recombinant human alpha-N-acetylglucosaminidase (rhNAGLU) intended as an enzyme replacement therapy for patients who lack rhNAGLU enzyme activity. TA-ERT is designed to restore rhNAGLU enzyme activity in the central nervous system following intracerebroventricular injection and promote clearance of heparan sulfate in the brain.
35GF Score

Get the complete analysis for SPRB

Purchase Of Property, Plant, Equipment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$51.31
Price
$4.08
GF Value